Latent Autoimmune Diabetes of the Adult (LADA), is a type of diabetes presenting with clinical features resembling Type 2 diabetes. Immunologically LADA is characterized by islet directed auto-antibodies and is considered a form of Type 1 diabetes. Antibodies are part of bodies immune response and specific antibodies are associated with autoimmunity.
People with LADA do not usually require insulin for the first 3 to 6 months following diagnosis, but up to 80% will require insulin within the next five years. Some physicians treat LADA electively with insulin before their blood sugars get out of control, but many patients are treated according to standard management guidelines for Type 2 diabetes.
For more information refer to http://www.diabetes.co.uk/diabetes_lada.html